Navigation path

Community Register of medicinal products

Community register of orphan medicinal products


GRANTED  

Product information

N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide

EU orphan designation number: EU/3/07/526   
Active ingredient: N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide
Indication: Treatment of acute myeloid leukaemia
Sponsor: CanReg (Europe) Limited
Templetown, Carlingford, County Louth, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/02/2008 Centralised Orphan - Designation EMEA/OD/099/07 (2008)450 of 31/01/2008
06/11/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/099/07/T/01 (2008)6719 of 04/11/2008
27/03/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/099/07/T/02 (2009)2319 of 25/03/2009